MyFinsight
Home
Blog
About
Marketable securities
$99,502K
(-21.09%↓ Y/Y)
Cash and cash
equivalents
$68,080K
(-6.19%↓ Y/Y)
Prepaid expenses and
other current assets
$2,464K
(-37.25%↓ Y/Y)
Total current assets
$170,046K
(-16.58%↓ Y/Y)
Operating lease
right-of-use assets
$29,847K
(174.48%↑ Y/Y)
Restricted cash
$2,000K
(0.00%↑ Y/Y)
Property and equipment,
net
$1,497K
(-84.27%↓ Y/Y)
Other assets
$3K
(-50.00%↓ Y/Y)
Total assets
$203,393K
(-10.10%↓ Y/Y)
Accumulated deficit
-$659,533K
(-10.85%↓ Y/Y)
Accumulated other
comprehensive gain (loss)
-$134K
(-204.55%↓ Y/Y)
Total liabilities and
stockholders deficit
$203,393K
(-10.10%↓ Y/Y)
Total stockholders
deficit
-$81,041K
(-5.72%↓ Y/Y)
Additional paid-in capital
$578,620K
(11.63%↑ Y/Y)
Common stock, 0.0001
par value...
$6K
(0.00%↑ Y/Y)
Total liabilities
$284,434K
(-6.09%↓ Y/Y)
Deferred revenue, net of
current portion
$193,222K
(-6.58%↓ Y/Y)
Total current
liabilities
$50,579K
(-34.98%↓ Y/Y)
Operating lease
liabilities, net of current...
$40,283K
(129.90%↑ Y/Y)
Other liabilities
$350K
(-53.76%↓ Y/Y)
Deferred revenue
$36,593K
(-38.73%↓ Y/Y)
Accrued expenses and
other current...
$7,960K
(-7.05%↓ Y/Y)
Accounts payable
$3,207K
(-3.46%↓ Y/Y)
Operating lease
liabilities
$2,819K
(-54.36%↓ Y/Y)
Back
Back
Balance Sheet
Foghorn Therapeutics Inc. (FHTX)
Foghorn Therapeutics Inc. (FHTX)
source: myfinsight.com